China SXT Pharmaceuticals, Inc.

SXTC Healthcare Drug Manufacturers Specialty & Generic

China SXT Pharmaceuticals, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 million, down 34.6% from fiscal 2025.

0.07 0.00 0.00%
Market cap
$710.0K
P/E
0.0×
Fwd P/E
−1.0×
Dividend yield
—
F-score
3/9
Altman Z
−0.84
Beneish M
−2.12
Dividend safety
n/a
Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Piotroski F-Score
— 8 4 4 5 4 — — — 3
P/E ratio
143.50 143.50 101.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
— — 15,873,085.12 202,635.77 12,820.94 3,060.50 — — (1.00) (0.84)
P/S ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
4.34 4.36 6.57 1.53 0.42 (0.51) (1.51) (1.11) 2.19 7.29
Beneish M-Score
(1.84) 1.39 (1.99) (5.10) 1.90 (3.48) (3.42) (2.68) (2.47) (2.12)
P/Operating CF
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/B ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.00 0.00 0.00 (0.05) (1.34) (1.83) (3.04) (2.11) (3.79) (5.94)
EV/EBITDA
0.00 0.00 0.00 0.00 4.65 2.01 1.36 0.95 1.69 2.66
EV/FCF
0.00 0.00 (3.72) 0.18 3.73 6.79 16.41 2.93 2.80 2.90
Current Ratio
1.37 1.40 2.47 1.60 1.25 1.31 1.35 1.60 3.54 7.93
Net Debt/EBITDA
0.14 (0.15) (4.73) 0.56 7.19 2.78 2.60 4.18 6.67 3.86
Debt/Equity
0.16 0.12 0.01 0.72 0.00 0.12 0.23 0.17 0.05 0.03
ROE
91.32% 46.22% 21.39% (100.32%) (21.67%) (35.42%) (38.15%) (21.65%) (22.50%) (27.49%)
ROA
20.21% 18.15% 12.25% (52.53%) (9.77%) (16.85%) (18.81%) (11.76%) (14.75%) (22.00%)
ROIC
47.93% 33.86% 58.66% (9.48%) (51.90%) (111.79%) (453.09%) (36.86%) 0.00% (175.91%)
Return on Tangible Assets
65.42% 45.81% 14.76% (114.99%) (45.15%) (87.47%) (99.13%) (54.74%) (21.37%) (20.49%)
Average Days of Receivables
281.88 142.29 217.62 324.38 344.33 467.52 248.91 248.85 360.39 963.70
Earnings Yield
0.70% 0.70% 0.99% 0.00% 0.00% (0.14%) (0.13%) (0.56%) (0.37%) (82.82%)
Free Cash Flow Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
0.01 0.04 (0.02) 0.09 (1.96) 0.20 0.00 0.00 (22,818.00) (472.65)
Book value per Share
0.09 0.16 0.54 1.52 22.18 15.79 0.00 0.00 154,398.00 3,494.99
Free Cash Flow
0.11 0.87 (0.37) 0.53 (1.41) 0.21 (0.15) (1.94) (2.28) (4.02)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates